← All stories
Markets
Discover AstraZeneca (LSE:AZN) Advancing Lung Cancer Care
Highlights New oral therapy combination delivers encouraging clinical trial results. Treatment targets a major challenge in advanced lung cancer care. Global regulatory submissions are expected following the latest findings. AstraZeneca has…
Covered by 1 outlet
All coverage · 1 article